Vaccines save lives by protecting people against infectious diseases—polio, influenza, and malaria to name a few. Kaiser Permanente Washington Health Research Institute (KPWHRI) is working to protect communities through research to continually improve the safety and effectiveness of vaccines and other treatments for infectious diseases as well as cancer. We also test new vaccines that may stop the threat of emerging diseases such as the novel coronavirus (SARS-CoV-2), which causes COVID-19.
Our research projects on vaccines and infectious diseases include:
Successes over 3 decades of KPWHRI research on vaccines and preventing and treating infectious disease include:
Hesse EM, Navarro RA, Daley MF, Getahun D, Henninger ML, Jackson LA, Nordin J, Olson SC, Zerbo O, Zheng C, Duffy J. Risk for subdeltoid bursitis after influenza vaccination: a population-based cohort study. Ann Intern Med. 2020 Jun 23. doi: 10.7326/M19-3176. [Epub ahead of print]. PubMed
Jackson ML, Scott E, Kuypers J, Nalla AK, Roychoudury P, Chu HY. Epidemiology of respiratory syncytial virus across five influenza seasons among adults and children one year of age and older - Washington State, 2011/12 - 2015/16. LID - jiaa331 [pii] LID - 10.1093/infdis/jiaa331 [doi] J Infect Dis. 2020 Jun 19:jiaa331. doi: 10.1093/infdis/jiaa331 [Epub ahead of print] PubMed
Parodi S, Choucair B, Young S, Bellow J, Grossman D, Liu VX. Kaiser Permanente’s system capabilities to suppress Covid-19. N Eng J Med Catal. June 9, 2020. DOI: 10.1056/CAT.20.0187.
Kim SS, Flannery B, Foppa IM, Chung JR, Nowalk MP, Zimmerman RK, Gaglani M, Monto AS, Martin ET, Belongia EA, McLean HQ, Jackson ML, Jackson LA, Patel M. Effects of prior season vaccination on current season vaccine effectiveness in the US Flu VE Network, 2012-13 through 2017-18. Clin Infect Dis. 2020 Jun 7:ciaa706. doi: 10.1093/cid/ciaa706. [Epub ahead of print]. PubMed
Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB. Methodological considerations in calculating and analyzing proportion of time covered as a measure of longitudinal cancer screening adherence. Cancer Epidemiol Biomarkers Prev. 2020 May 28:cebp.0388.2020. doi: 10.1158/1055-9965.EPI-20-0388. [Epub ahead of print]. PubMed
![]() Lisa A. Jackson, MD, MPHSenior Investigator |
![]() Jennifer C. Nelson, PhDDirector of Biostatistics; Senior Investigator |
![]() Michael L. Jackson, PhD, MPHSenior Investigator |
![]() Andrea J. Cook, PhDSenior Investigator |
![]() Sascha Dublin, MD, PhDSenior Investigator |
![]() Onchee Yu, MSBiostatistician III |
![]() Robert D. Wellman, MSBiostatistician III |
Doug Opel, MD, MPH
University of Washington (UW) Department of Bioethics and Humanities; UW Department of Pediatrics; UW Medical Center
John Dunn, MD, MPH
Kaiser Foundation Health Plan of Washington
Elizabeth Lin, MD, MPH
Kaiser Foundation Health Plan of Washington Family Practice;
Kaiser Permanente Washington Health Research Institute